Although rare, with an incidence of 0.4 to 2 per 100,000, Guillain-Barré syndrome (GBS) has major effects on the healthcare system. The cost of medical care for a patient with GBS has been estimated at up to $318,966. Overall, the cost of treating patients with GBS has been estimated at $1.7 billion dollars per year. Males are affected at a slightly higher incidence than females. Each year, it is estimated 100,000 patients worldwide would contract GBS.